As the cancer cells tested do not express CXCL13 (a ligand for CXCR5), the novel role of CXCR5 in ovarian cancer cells in response to EGF or TNF may highlight their interaction with immune cells expressing CXCL13 in the tumor microenvironment. This evidence concerns the gene EGF and ovarian cancer.